Your browser doesn't support javascript.
loading
Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project.
Leuchter, Andrew F; McGough, James J; Korb, Alexander S; Hunter, Aimee M; Glaser, Paul E A; Deldar, Ahmed; Durell, Todd M; Cook, Ian A.
Affiliation
  • Leuchter AF; Department of Psychiatry and Biobehavioral Sciences, and the Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA; UCLA Depression Research and Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, L
  • McGough JJ; Child and Adolescent Psychopharmacology and Attention-Deficit/Hyperactivity Disorder Programs, Division of Child and Adolescent Psychiatry, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Korb AS; Department of Psychiatry and Biobehavioral Sciences, and the Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA; UCLA Depression Research and Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, L
  • Hunter AM; Department of Psychiatry and Biobehavioral Sciences, and the Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA; UCLA Depression Research and Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, L
  • Glaser PE; Departments of Psychiatry, Pediatrics, and Anatomy and Neurobiology, University of Kentucky, Lexington, KY, USA.
  • Deldar A; Eli Lilly and Company and/or one of its subsidiaries, Indianapolis, IN, USA.
  • Durell TM; Eli Lilly and Company and/or one of its subsidiaries, Indianapolis, IN, USA.
  • Cook IA; Department of Psychiatry and Biobehavioral Sciences, and the Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA; UCLA Depression Research and Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, L
J Psychiatr Res ; 54: 11-8, 2014 Jul.
Article in En | MEDLINE | ID: mdl-24726639
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propylamines / Attention Deficit Disorder with Hyperactivity / Adrenergic Uptake Inhibitors / Brain Waves Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: J Psychiatr Res Year: 2014 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propylamines / Attention Deficit Disorder with Hyperactivity / Adrenergic Uptake Inhibitors / Brain Waves Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: J Psychiatr Res Year: 2014 Document type: Article Country of publication: United kingdom